Bronchopulmonary Dysplasia
"Bronchopulmonary Dysplasia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
Descriptor ID |
D001997
|
MeSH Number(s) |
C08.381.520.750.500 C16.614.521.125
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Bronchopulmonary Dysplasia".
Below are MeSH descriptors whose meaning is more specific than "Bronchopulmonary Dysplasia".
This graph shows the total number of publications written about "Bronchopulmonary Dysplasia" by people in this website by year, and whether "Bronchopulmonary Dysplasia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 2 | 0 | 2 |
2007 | 2 | 0 | 2 |
2008 | 1 | 0 | 1 |
2011 | 0 | 1 | 1 |
2014 | 3 | 0 | 3 |
2015 | 2 | 0 | 2 |
2016 | 1 | 0 | 1 |
2017 | 0 | 1 | 1 |
2018 | 1 | 0 | 1 |
2019 | 3 | 1 | 4 |
2020 | 2 | 0 | 2 |
2021 | 2 | 0 | 2 |
2022 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bronchopulmonary Dysplasia" by people in Profiles.
-
Association of Fluid Balance With Short- and Long-term Respiratory Outcomes in Extremely Premature Neonates: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2022 12 01; 5(12):e2248826.
-
Changes Overtime in Perinatal Management and Outcomes of Extremely Preterm Infants in One Tertiary Care Romanian Center. Medicina (Kaunas). 2022 Jul 29; 58(8).
-
Postnatal steroid management in preterm infants with evolving bronchopulmonary dysplasia. J Perinatol. 2021 08; 41(8):1783-1796.
-
Lymphocyte-Specific Biomarkers Associated With Preterm Birth and Bronchopulmonary Dysplasia. Front Immunol. 2020; 11:563473.
-
Antioxidant MnTBAP does not protect adult mice from neonatal hyperoxic lung injury. Respir Physiol Neurobiol. 2020 11; 282:103545.
-
Urine gastrin-releasing peptide in the first week correlates with bronchopulmonary dysplasia and post-prematurity respiratory disease. Pediatr Pulmonol. 2020 04; 55(4):899-908.
-
Respiratory medication use in extremely premature (<29 weeks) infants during initial NICU hospitalization: Results from the prematurity and respiratory outcomes program. Pediatr Pulmonol. 2020 02; 55(2):360-368.
-
Retrospective Analysis of Short-Term Respiratory Outcomes of Three Different Steroids Used in Clinical Practice in Intubated Preterm Infants. Am J Perinatol. 2020 12; 37(14):1425-1431.
-
Respiratory Medications in Infants <29?Weeks during the First Year Postdischarge: The Prematurity and Respiratory Outcomes Program (PROP) Consortium. J Pediatr. 2019 05; 208:148-155.e3.
-
Black Race Is Associated with a Lower Risk of Bronchopulmonary Dysplasia. J Pediatr. 2019 04; 207:130-135.e2.